Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters.
Zhai TT, van Dijk LV, Huang BT, Lin ZX, Ribeiro CO, Brouwer CL, Oosting SF, Halmos GB, Witjes MJH, Langendijk JA, Steenbakkers RJHM, Sijtsema NM. Zhai TT, et al. Among authors: oosting sf. Radiother Oncol. 2017 Aug;124(2):256-262. doi: 10.1016/j.radonc.2017.07.013. Epub 2017 Jul 29. Radiother Oncol. 2017. PMID: 28764926 Free article.
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM, Griebsch I, Bottomley A; SISAQOL-IMI Consortium. Pe M, et al. Lancet Oncol. 2023 Jun;24(6):e270-e283. doi: 10.1016/S1470-2045(23)00157-2. Lancet Oncol. 2023. PMID: 37269858 Free article. Review.
Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients.
Vermaat JS, Gerritse FL, van der Veldt AA, Roessingh WM, Niers TM, Oosting SF, Sleijfer S, Roodhart JM, Beijnen JH, Schellens JH, Gietema JA, Boven E, Richel DJ, Haanen JB, Voest EE. Vermaat JS, et al. Among authors: oosting sf. Eur Urol. 2012 Oct;62(4):685-95. doi: 10.1016/j.eururo.2012.01.020. Epub 2012 Jan 23. Eur Urol. 2012. PMID: 22285764
A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model.
Boomsma MJ, Bijl HP, Christianen ME, Beetz I, Chouvalova O, Steenbakkers RJ, van der Laan BF, Wolffenbuttel BH, Oosting SF, Schilstra C, Langendijk JA. Boomsma MJ, et al. Among authors: oosting sf. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e351-6. doi: 10.1016/j.ijrobp.2012.05.020. Epub 2012 Jun 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 22717243
Development and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in head and neck cancer.
Wopken K, Bijl HP, van der Schaaf A, Christianen ME, Chouvalova O, Oosting SF, van der Laan BF, Roodenburg JL, Leemans CR, Slotman BJ, Doornaert P, Steenbakkers RJ, Verdonck-de Leeuw IM, Langendijk JA. Wopken K, et al. Among authors: oosting sf. PLoS One. 2014 Apr 15;9(4):e94879. doi: 10.1371/journal.pone.0094879. eCollection 2014. PLoS One. 2014. PMID: 24736318 Free PMC article.
Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.
Bollineni VR, Koole MJ, Pruim J, Brouwer CL, Wiegman EM, Groen HJ, Vlasman R, Halmos GB, Oosting SF, Langendijk JA, Widder J, Steenbakkers RJ. Bollineni VR, et al. Among authors: oosting sf. Radiother Oncol. 2014 Nov;113(2):198-203. doi: 10.1016/j.radonc.2014.10.010. Epub 2014 Nov 27. Radiother Oncol. 2014. PMID: 25434768
Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer.
Wopken K, Bijl HP, van der Schaaf A, van der Laan HP, Chouvalova O, Steenbakkers RJ, Doornaert P, Slotman BJ, Oosting SF, Christianen ME, van der Laan BF, Roodenburg JL, Leemans CR, Verdonck-de Leeuw IM, Langendijk JA. Wopken K, et al. Among authors: oosting sf. Radiother Oncol. 2014 Oct;113(1):95-101. doi: 10.1016/j.radonc.2014.09.013. Epub 2014 Oct 16. Radiother Oncol. 2014. PMID: 25443500 Free article.
Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia.
van der Laan HP, Bijl HP, Steenbakkers RJ, van der Schaaf A, Chouvalova O, Vemer-van den Hoek JG, Gawryszuk A, van der Laan BF, Oosting SF, Roodenburg JL, Wopken K, Langendijk JA. van der Laan HP, et al. Among authors: oosting sf. Radiother Oncol. 2015 Apr;115(1):56-62. doi: 10.1016/j.radonc.2015.01.019. Epub 2015 Mar 16. Radiother Oncol. 2015. PMID: 25792467 Free article.
Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation.
Christianen ME, Verdonck-de Leeuw IM, Doornaert P, Chouvalova O, Steenbakkers RJ, Koken PW, Leemans CR, Oosting SF, Roodenburg JL, van der Laan BF, Slotman BJ, Bijl HP, Langendijk JA. Christianen ME, et al. Among authors: oosting sf. Radiother Oncol. 2015 Oct;117(1):139-44. doi: 10.1016/j.radonc.2015.07.042. Epub 2015 Aug 25. Radiother Oncol. 2015. PMID: 26320608 Free article.
108 results